The changing face of diabetes complications (Q38828410)

6 September 2017

1 reference

title

The changing face of diabetes complications (English)

1 reference

6 September 2017

1

Edward W Gregg

1 reference

6 September 2017

Naveed Sattar

2

1 reference

PubMed ID

27156051

6 September 2017

Mohammed K Ali

series ordinal

3

1 reference

6 September 2017

4 May 2016

1 reference

The Lancet: Diabetes & Endocrinology

6 September 2017

1 reference

6 September 2017

4

1 reference

6 September 2017

6

1 reference

6 September 2017

537-547

1 reference

Diabetes: a 21st century challenge

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global estimates of diabetes prevalence for 2013 and projections for 2035.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The many faces of diabetes: a disease with increasing heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Long-term complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

ABC of arterial and venous disease: vascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Dysglycaemia, vasculopenia, and the chronic consequences of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes: Advances in Diagnosis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Achievement of goals in U.S. diabetes care, 1999-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The status of diabetes control in Asia--a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The epidemiology of diabetes and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Changes in diabetes-related complications in the United States, 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in cardiovascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Lower extremity amputations--a review of global variability in incidence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The Danish National Diabetes Register: trends in incidence, prevalence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004-2009

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetic neuropathies: a statement by the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Substantial reduction in the number of amputations among patients with diabetes: a cohort study over 16 years

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Temporal trends in initial and recurrent lower extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Decreasing amputation rates in patients with diabetes-a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005: results of the Leverkusen Amputation Reduction Study (LARS)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Sustained reduction in major amputations in diabetic patients: 628 amputations in 461 patients in a defined population over a 20-year period

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Incidence of lower limb amputations in individuals with and without diabetes mellitus in Andalusia (Spain) from 1998 to 2006

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000-2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

High Israeli mortality rates from diabetes and renal failure - Can international comparison of multiple causes of death reflect differences in choice of underlying cause?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Excess Mortality among Persons with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Chronic kidney disease: global dimension and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Global prevalence and major risk factors of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Time trends in the incidence and causes of blindness in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Secular trends in diabetes-related preventable hospitalizations in the United States, 1998-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Declining death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985-2002

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The decline in mortality due to acute complications of diabetes mellitus in Brazil, 1991-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The WHO Multinational Study of Vascular Disease in Diabetes: 3. Microvascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The WHO Multinational Study of Vascular Disease in Diabetes: 2. Macrovascular Disease Prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Ethnic disparities in diabetic complications in an insured population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008*.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in cigarette smoking rates and quit attempts among adults with and without diagnosed diabetes, United States, 2001-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

A cascade of care for diabetes in the United States: visualizing the gaps.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0-29 years in West Yorkshire, U.K., 1991-2006

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Do men develop type 2 diabetes at lower body mass indices than women?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Earlier onset of complications in youth with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

The lifetime cost of diabetes and its implications for diabetes prevention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Diabetes and risk of physical disability in adults: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930010-9

7 January 2021

10.1016/S2213-8587(16)30010-9

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

27156051